These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 35984137

  • 1. Bone densitometry in children with idiopathic nephrotic syndrome on prolonged steroid therapy: A tertiary multicenter study.
    Soliman ASA, Abukhatwah MW, Kamal NM, Sweed EMM, Alelyani AM, Althobaiti SD, Alzaedi MA, El-Rebigi AM, Besher NT, Abukhatwah OMW, Alharbi AO, Afifi WE.
    Medicine (Baltimore); 2022 Aug 19; 101(33):e29860. PubMed ID: 35984137
    [Abstract] [Full Text] [Related]

  • 2. Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease?
    Gulati S, Godbole M, Singh U, Gulati K, Srivastava A.
    Am J Kidney Dis; 2003 Jun 19; 41(6):1163-9. PubMed ID: 12776267
    [Abstract] [Full Text] [Related]

  • 3. Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.
    Singh DN, Krishnamurthy S, Kamalanathan SK, Harichandrakumar KT, Sivamurukan P.
    Paediatr Int Child Health; 2018 Nov 19; 38(4):251-260. PubMed ID: 30092157
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reduced spinal bone mineral density in adolescents of an Ultra-Orthodox Jewish community in Brooklyn.
    Taha W, Chin D, Silverberg AI, Lashiker L, Khateeb N, Anhalt H.
    Pediatrics; 2001 May 19; 107(5):E79. PubMed ID: 11331729
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of Bone Mineral Density Using DXA and cQCT in Postmenopausal Patients Under Thyrotropin Suppressive Therapy.
    Kim K, Kim IJ, Pak K, Kim SJ, Shin S, Kim BH, Kim SS, Lee BJ, Jeon YK.
    J Clin Endocrinol Metab; 2018 Nov 01; 103(11):4232-4240. PubMed ID: 29982711
    [Abstract] [Full Text] [Related]

  • 12. Increased Bone Mineral Density in Cervical or Thoracic Diffuse Idiopathic Skeletal Hyperostosis (DISH): A Case-Control Study.
    Sohn S, Chung CK, Han I, Park SB, Kim H.
    J Clin Densitom; 2018 Nov 01; 21(1):68-74. PubMed ID: 27712986
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of osteoporosis and osteopenia diagnosed using quantitative CT in 296 consecutive lumbar fusion patients.
    Carlson BB, Salzmann SN, Shirahata T, Ortiz Miller C, Carrino JA, Yang J, Reisener MJ, Sama AA, Cammisa FP, Girardi FP, Hughes AP.
    Neurosurg Focus; 2020 Aug 01; 49(2):E5. PubMed ID: 32738803
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bone mineral density in children and young adults with idiopathic scoliosis: a systematic review and meta-analysis.
    Yang Y, Han X, Chen Z, Li X, Zhu X, Yuan H, Huang Z, Zhou X, Du Q.
    Eur Spine J; 2023 Jan 01; 32(1):149-166. PubMed ID: 36450863
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of osteopenia in men with prolactinoma.
    Naliato EC, Farias ML, Braucks GR, Costa FS, Zylberberg D, Violante AH.
    J Endocrinol Invest; 2005 Jan 01; 28(1):12-7. PubMed ID: 15816365
    [Abstract] [Full Text] [Related]

  • 17. Effect of two prophylactic bolus vitamin D dosing regimens (1000 IU/day vs. 400 IU/day) on bone mineral content in new-onset and infrequently-relapsing nephrotic syndrome: a randomised clinical trial.
    Muske S, Krishnamurthy S, Kamalanathan SK, Rajappa M, Harichandrakumar KT, Sivamurukan P.
    Paediatr Int Child Health; 2018 Feb 01; 38(1):23-33. PubMed ID: 28466679
    [Abstract] [Full Text] [Related]

  • 18. Markers of bone metabolism in children with nephrotic syndrome treated with corticosteroids.
    Pańczyk-Tomaszewska M, Adamczuk D, Kisiel A, Skrzypczyk P, Przedlacki J, Górska E, Stelmaszczyk-Emmel A, Demkow U, Roszkowska-Blaim M.
    Adv Exp Med Biol; 2015 Feb 01; 840():21-8. PubMed ID: 25310960
    [Abstract] [Full Text] [Related]

  • 19. Bone mineral density in patients with pancreatic insufficiency and steatorrhea.
    Morán CE, Sosa EG, Martinez SM, Geldern P, Messina D, Russo A, Boerr L, Bai JC.
    Am J Gastroenterol; 1997 May 01; 92(5):867-71. PubMed ID: 9149203
    [Abstract] [Full Text] [Related]

  • 20. Sex steroids, biochemical markers, bone mineral density and histomorphometry in male osteoporosis patients.
    Fassbender WJ, Balli M, Görtz B, Hinrichs B, Kaiser HE, Tracke HS.
    In Vivo; 2000 May 01; 14(5):611-8. PubMed ID: 11125545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.